• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Curr Opin Clin Nutr Metab Care. Author manuscript; available in PMC Nov 1, 2011.
Published in final edited form as:
PMCID: PMC2964392
NIHMSID: NIHMS237439

Nutritional determinants of mobility

Yuri Milaneschi, Psy D,1 Toshiko Tanaka, PhD,1,2 and Luigi Ferrucci, MD, PhD1

Abstract

Purpose of review

In many countries, persons over 65 is one of the fastest growing segment of the population. Mobility disability is one of the major risk factors for morbidity and mortality in this age group. There is increasing evidence that improved nutrition can reduce the risk of developing disability in older age. This review summarizes the recent literature showing the associations between different nutrients and mobility-related outcomes in older adults.

Recent findings

Recent studies suggested an association between low intake and low serum concentrations of micronutrients, such as antioxidants and vitamins, with measures of physical performance, muscle strength and disability in older adults.

Summary

The role of low micronutrients as cross-sectional and longitudinal correlates of mobility disability is consistent with a growing number of studies showing that a diet rich in fruits and vegetables, such as the Mediterranean diet, has a beneficial role in healthy aging.

Keywords: Mobility, aging, nutrition, antioxidants, vitamins, AGEs

Introduction

Mobility underlies the ability to perform basic activities of daily living (ADLs) necessary for independence and is a core indicator of health and function in aging. Mobility difficulties are highly predictive of more severe disablement, which affect older people’s independence and quality of life, and impose considerable burden on caregivers and health care system [1]. Measures of physical performance have been shown to predict adverse health events, such as nursing home admission, disability and death among older adults [24*]. Thus, mobility disability is a marker of a high risk group for whom interventions may well be beneficial in preventing further decline in function. Understanding the determinants of mobility decline is crucial in order to identify interventions that may prevent functional decline and delay the onset of disability. In recent years, several epidemiological studies suggested an association between low intake and serum concentrations of different nutrients and poor mobility outcomes. Among older persons, different factors can lead to a decline in food intake such as eating-difficulties, alterations of stomach-fundus compliance, activity of cholecystokin, depression and inflammatory process. Decline in overall food consumption increases the risk of inadequate intake of essential nutrients [5,6]. The purpose of this review is to highlight recent research examining the association of different nutrients and bioactive compounds with mobility-related outcomes.

Dietary intake

Protein consumption is essential for maintenance of muscle mass and strength particularly in the elderly. In community-dwelling older people from the Health, Aging and Body Composition Study (Health-ABC), low protein intake was associated with loss of muscle mass (as measured by DEXA) during 3-year follow-up [7]. These findings are consistent with the observation of low protein intake was associated higher prevalence of frailty, a syndrome characterized by low muscle strength and poor physical performance, in InCHIANTI study participants older than 65 years of age [8]. Frailty is associated with higher risk of accelerated physical and functional decline, disability and death in older persons, therefore reducing the risk for frailty is critical [9]. There is no consensus on the degree to which dietary protein needs change with advancing age. Studies aimed at prevent muscle/strength loss in older persons via protein-energy supplementation have obtained conflicting results, in particular, protein supplementation trials involving frail patients have been unsuccessful [10**]. A definitive answer to the question of whether protein supplementation may prevent or delay physical disability in older adults requires randomized clinical trials on large samples, long follow-up and multiple outcomes. However, the administration of large quantities of proteins in older individuals raises some concerns. Protein supplementation increases satiety inducing a compensatory decrease of voluntary food ingestion [11]. Moreover, it appears [12] that aging may be associated with reduced anabolic efficiency in response to carbohydrate coingestion. Finally, there is evidence that that a higher protein intake may accelerate greater decline in renal function in those with modest renal insufficiency [11].

Consumption of specific micronutrients have also been associated with mobility-related outcomes. In the InCHIANTI study, higher dietary intake of vitamin-C was significantly correlated with measures of knee extension and lower extremity performance as assessed by SPPB (Short Physical Performance Battery) [13]. Similary, Bartali et al. [8] reported an association between low intake of vitamin D, E C with prevalence of frailty.

Nutrient Biomarkers

Nutrient biomarkers have been extensively studied in association with physical function. Plasma concentrations of α- and γ-tocopherol (vitamin-E) were positively correlated with physical performance and strength. Ble et al. [14] confirmed an association between low circulating levels of vit-E and the presence of frailty in the InCHIANTI sample. In a longitudinal analysis [15], participants in the lowest quartile of serum α-tocopherol were more likely to develop lower extremity physical decline (loss of at least 1 point in SPPB) during a 3-year follow-up. Similar findings were obtained by the Women’s Health and Aging Study (WHAS). At baseline, frail women had significantly lower serum concentrations of vitamin D, E and B6 and carotenoids, as compared to their non-frail peers [16, 17]. Moreover, non frail women in the lowest quartiles of serum α-tocopherol, 25-hydroxyvitamin-D [25(OH)D] and carotenoids had an increased risk of becoming frail during the follow-up [16]. Furthemore, women in the lowest quartile of serum concentrations of vitamin B6, B12 and selenium had significantly higher risk of developing disability in ADLs during a 3-year follow-up compared with women in the upper quartiles [18].

The six major dietary carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lutein, zeaxanthin, and lycopene) comprise an important component of the antioxidant defense system in humans, and are considered a good indicator of fruit and vegetable intake [19]. Among older women in WHAS, low serum carotenoids were associated with poor grip, hip, and knee muscle strength after adjustment for age, race, smoking, cardiovascular disease, arthritis, and IL-6 [20]. Further investigation showed that among women without severe walking disability (inability to walk or walking speed <0.4 m/sec) at baseline, women in the lowest quartile of serum carotenoids were at higher risk of developing severe walking disability over 36 months of follow-up [21]. More recently, it has been reported that serum carotenoids were associated with mean walking speed over three years of follow-up and with rate of change of walking speed adjusting for age, BMI and chronic disease [22**]. From the InCHIANTI Study, Lauretani et al. [23] reported that participants in the lowest quartile of plasma carotenoids had higher decline in hip flexion and knee extension power and hand-grip strength than those in the upper three quartiles at six-year follow-up. Moreover, higher total plasma carotenoids were associated with a significantly lower risk of developing severe walking disability and a less steep decline in 4-meter walking speed over six years of follow-up, and lower incidence rates of being unable to successfully complete the 400-meter walking test at the 6-year follow-up visit [24].

Selenium is a trace element that exerts antioxidative functions in myocytes and other tissues after integration into proteins. In the InCHIANTI study populations, more than 30% of older adults in the InCHIANTI Study had a plasma selenium concentration <0.88 µmol/L, the concentration below which selenium may be limiting the synthesis of selenoproteins [25]. At baseline, participants in the lowest versus the highest quartile of plasma selenium were at higher risk of poor hip, knee and grip strength after adjustment for age, sex education, total energy intake BMI, and chronic disease [25]. Similarly, among disabled women in the WHAS, after adjusting for age, race, BMI, MMSE, current smoking, hypertension, congestive heart failure and depression, higher serum selenium was associated with higher grip strength [26].

Antioxidants play an important role in counterbalancing the age-dependent increase in oxidative stress. With aging, increased oxidative damage to DNA, protein and lipids has been described in skeletal muscle with associated atrophy and loss of muscle fibers [27]. Analyses conducted on the WHAS sample have shown that serum protein carbonyls, markers of oxidative damage to proteins, were associated with poor grip strength [28], incident severe walking disability [29] and mortality [30]. Antioxidants may play a preventive role in muscle damage by reducing oxidative injury through the quenching of hydroxyl radicals and reduction in lipid peroxidation [31]. By reducing free radical concentrations, antioxidants may modulate redox balance and activation of nuclear factor κB, a major transcriptional factor involved in the expression of proinflammatory cytokines [32], which are associated with loss of muscle strength, reduced physical function and disability [33, 34]. Walston et al [35]reported that WHAS participants with the highest serum levels of carotenoids and selenium were significantly less likely to be in the highest tertile of serum IL-6 at baseline; those with the lowest levels of carotenoids were significantly more likely to have increasing IL-6 levels over a period of 2 years, and those with the lowest selenium levels had a significantly higher risk of total mortality over a period of 5 years.

Vitamin D

Vitamin D insufficiency in older persons is highly prevalent worldwide [36]. While more than 90% of the vit-D requirement comes from exposure to sunlight, a smaller part comes from food intake. Nutritional sources of vit-D are mostly limited to oily fish (salmon, mackerel, and sardines) which are not regularly consumed [36]. Vit-D nutritherapy through dietary supplements and consumption of enriched foods has been proposed as a strategy to prevent sarcopenia (the progressive reduction in muscle mass and strength prevalent in late-life) [37*].

Studies testing the relationship between Vit-D and physical performance yielded mixed results. Among participants aged ≥65 years in the Longitudinal Aging Study Amsterdam (LASA) [38], those with lower serum 25(OH)D, as compared to those with higher levels, had poorer physical performance at baseline and higher odds ratios of 3-year decline in physical performance after adjusting for age, gender, chronic diseases, degree of urbanization, BMI, and alcohol consumption. From the InCHIANTI Study, Shardell et al. [39**] reported that in older men, lower serum 25(OH)D was associated with frailty. In a recent analysis (Semba et al., unpublished observations) among InCHIANTI participants, those in the highest quartile of serum 25(OH)D at baseline had higher walking speed at baseline, and at 3- a 6-year follow-up compared to those in the lowest quartile. A systematic review by Annweiller et al. [40**] examined publications about the effects of low serum Vit-D concentration and Vit-D supplementation on physical performance among people aged ≥65 years. Authors identified eight observational and eight interventional studies. Among the observational studies, five showed a significant positive association between physical performance and serum 25(OH)D, whereas three studies showed no significant association. Among the interventional studies, four of the five studies and two of the three studies testing the vit-D supplementation effect on balance and gait respectively found no significant effect. Four studies showed a significant effect on muscle strength while three studies did not. A recent meta-analysis by Bischoff-Ferrari et al. [41**] based on eight double-blind randomized controlled trials (RCTs) examined the benefit of supplementation on fall prevention. High dose (700–1000 IU per day) supplemental vit-D and achieved serum 25(OH)D ≥60nmol/L resulted in a reduction of falls of, respectively, 19% and 23%. Low dose supplementation or achieved serum 25(OH)D <60nmol/L did not reduced fall risk. In two RCTs, the active form of vitamin D (1α-hydroxyvitamin D and 1,25-dihydroxyvitamin D) reduced fall risk by 22%

Vit-D may influence mobility-related outcomes through different mechanisms. Vit-D receptors are present in human muscle tissue [42]; binding of vit-D to its nuclear receptor in muscle tissue may lead to de novo protein synthesis [43]. Positive effect of Vit-D on global physical performance may be due to its action on the nervous system, improving balance and neuromuscular control and coordination [40**].

The relationship between vit-D and mobility requires further investigation. Some studies found a significant association between low serum vit-D concentration and physical performance or vit-D-related improvement in physical performance, while others failed to show any association or effect of supplementation [40**,41**]. This discrepancy between studies is probably attributable to methodological issues such as variability in the results obtained by different assays, different threshold values used to define deficiency, insufficient control of confounders, high comorbidity in older subjects, type of vit-D supplemented, heterogeneity of dosage and association with other compounds [37*, 40**, 41**].

Advanced glycation end products

Advanced glycation end products (AGEs), are bioactive compounds found in foods and generated endogenously in the body by nonenzimatic glycation of proteins, lipids and DNA. Diet is a major source of exogenous AGEs, especially Western diets where foods are processed under elevated temperatures (broiling, roasting, deep frying, oven frying, or grilling) [44].

Recently, it has been hypothesized that AGEs could play a role in the pathogenesis of sarcopenia [45] and cross-sectional studies found evidence of a relationship between carboxymethyl-lysine (CML), a dominant AGE in serum and tissue, and sarcopenia-related outcomes. Among older disabled women in the WHAS [46**], those with elevated serum CML were at higher risk of poor grip strength adjusting for age, race, BMI, cognitive dysfunction depression and diabetes. From the InCHIANTI Study, Semba et al. [47**] reported that participants in the highest quartile of plasma CML were at higher risk of slow walking speed after adjustment for age, education, cognitive function, smoking and chronic diseases and after the exclusions of participants with diabetes. AGEs may play a role in sarcopenia through inflammation and endothelial dysfunction in the microcirculation of skeletal muscle [45] and though cross-linking of intramuscular connective tissue [48,49]. Prospective studies are needed to determine whether elevated serum AGEs predict decline in mobility measures.

Conclusion

Recent studies suggesting an association between different nutrients and mobility in older adults were revised. Attempts to translate the results from observational studies to dietary intervention trials may result in disappointing outcomes. There are various considerations when implementing diet interventions. First observation studies examine exposure to specific nutrients over an extended period of time while intervention studies usually have shorter exposure periods. Second, there is an inherent disconnection between observation trial of nutrients from the diet versus provided intervention based on supplementation of a single or multiple nutrients. For example, the role of protein requires further investigation based on longer-term trials with better define clinical endpoints; moreover, interventions via protein-energy supplementation in older persons have raised several concerns [10**,37*]. Observational and clinical trials testing the relationship between vit-D and physical performance provided mixed results [40**,41**]. Achievement of an adequate vit-D status through increasing nutritional intakes is difficult: less then 10% of the Vit-D requirement for most people comes from nutritional sources, very few foods naturally contain vit-D and fortification of foods policies varies widely across the world [36]. Finally, supplementation interventions require further clinical trials addressing important methodological issues such as type of Vit-D supplemented, dosage and association with other compounds. Further prospective studies are needed to confirm the relationship between AGEs and mobility-related outcomes [46**,47**]. AGEs are potentially an important modifiable risk factor, since diet is a major source of exogenous AGEs.

In the last few years epidemiological studies in older persons suggested that micronutrients with antioxidative capacity contained in fruit and vegetable, such as vitamins, carotenoids and selenium, are protective against physical function impairment and disability [8, 9, 1326].

There is increasing efforts to examine dietary patterns rather than single nutrients. Intervention that aims at improving overall diet quality may prove to have better success than single nutrient intervention. For example, among older adults in the Atherosclerosis Risk in Communities study, fruit and vegetable intake was inversely correlated with functional limitations and disability [49]. There is growing scientific evidence that the type of diet rich in fruits and vegetables, such as the Mediterranean diet, has a beneficial role in preventing cardiovascular diseases, cancer, and neurodegenerative disorders, and promoting quality of life and overall survival [50]. Recent trials showed that nutritional interventions based on Mediterranean-style diet significantly reduced the levels of inflammatory markers such as IL-6 and CRP [51,52], which are part of the hypothesized pathway that leads to loss of muscle strength, reduced physical function and disability. Epidemiological studies are needed to confirm whether a Mediterranean-style diet may reduce functional decline and the onset of disability in older persons. This could provide strong rationale and justification for dietary interventions studies aimed at reducing mobility impairment among older adults.

Acknowledgment

“The InCHIANTI study baseline (1998–2000) was supported as a “targeted project” (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001–2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the InCHIANTI Follow-ups 2 and 3 studies (2004–2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002);supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health

The authors thank Stefania Bandinelli (Geriatric Unit, Azienda Sanitaria Firenze, Florence, Italy) and Richard D Semba (Johns Hopkins University School of Medicine, Baltimore, MD, USA) for critical revision of the manuscript for important intellectual content.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

The authors do not have any conflict of interest in the publication of the manuscript.

References

Papers of particular interest, published within the annual period of review, have been highlighted as:

* of special interest

** of outstanding interest

1. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92–100. [PubMed]
2. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:85–94. [PubMed]
3. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561. [PubMed]
4. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009;13:881–889. [PubMed] In this review, a Task Force of the International Academy on Nutrition and Aging summarized the literature on the predictive capacity of usual gait speed in older persons.
5. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci. 2001;56:81–88. [PubMed]
6. Bartali B, Salvini S, Turrini A, Lauretani F, Russo CR, Corsi AM, Bandinelli S, D'Amicis A, Palli D, Guralnik JM, Ferrucci L. Age and disability affect dietary intake. J Nutr. 2003;133:2868–2873. [PubMed]
7. Houston DK, Nicklas BJ, Ding J, Harris TB, Tylavsky FA, Newman AB, Lee JS, Sahyoun NR, Visser M, Kritchevsky SB. Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr. 2008;87(1):150–155. [PubMed]
8. Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, Ferrucci L. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:589–593. [PMC free article] [PubMed]
9. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:146–156. [PubMed]
10. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009;12:86–90. [PubMed] The authors reviewed the role of protein and the amount of protein needed to preserve skeletal muscle mass in ageing.
11. Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR. Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr. 2008;87:1562S–1566S. [PubMed]
12. Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab. 2000;85:4481–4490. [PMC free article] [PubMed]
13. Cesari M, Pahor M, Bartali B, Cherubini A, Penninx BW, Williams GR, Atkinson H, Martin A, Guralnik JM, Ferrucci L. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr. 2004;79:289–294. [PubMed]
14. Ble A, Cherubini A, Volpato S, Bartali B, Walston JD, Windham BG, Bandinelli S, Lauretani F, Guralnik JM, Ferrucci L. Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2006;61:278–283. [PubMed]
15. Bartali B, Frongillo EA, Guralnik JM, Stipanuk MH, Allore HG, Cherubini A, Bandinelli S, Ferrucci L, Gill TM. Serum micronutrient concentrations and decline in physical function among older persons. JAMA. 2008;299:308–315. [PMC free article] [PubMed]
16. Semba RD, Bartali B, Zhou J, Blaum C, Ko CW, Fried LP. Low serum micronutrient concentrations predict frailty among older women living in the community. J Gerontol A Biol Sci Med Sci. 2006;61:594–599. [PubMed]
17. Michelon E, Blaum C, Semba RD, Xue QL, Ricks MO, Fried LP. Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci. 2006;61:600–607. [PubMed]
18. Bartali B, Semba RD, Frongillo EA, Varadhan R, Ricks MO, Blaum CS, Ferrucci L, Guralnik JM, Fried LP. Low micronutrient levels as a predictor of incident disability in older women. Arch Intern Med. 2006;166:2335–2340. [PMC free article] [PubMed]
19. Semba RD, Lauretani F, Ferrucci L. Carotenoids as protection against sarcopenia in older adults. Arch Biochem Biophys. 2007;458:141–145. [PMC free article] [PubMed]
20. Semba RD, Blaum C, Guralnik JM, Totin D, Ricks MO, Fried LP. Low carotenoid and vitamin E status are associated with indicators of sarcopenia among older women living in the community. Aging Clin Exp Res. 2003;15:482–487. [PubMed]
21. Semba RD, Varadhan R, Bartali B, Ferrucci L, Ricks MO, Blaum C, Fried LP. Low serum carotenoids and development of severe walking disability among older women living in the community: the women's health and aging study I. Age Ageing. 2007;36:62–67. [PMC free article] [PubMed]
22. Alipanah N, Varadhan R, Sun K, Ferrucci L, Fried LP, Semba RD. Low serum carotenoids are associated with a decline in walking speed in older women. J Nutr Health Aging. 2009;13:170–175. [PubMed] Using data from a population-based study of moderately to severely disabled older women, the authors found evidence of a cross-sectional and prospective independent association between serum carotenoids and walking speed.
23. Lauretani F, Semba RD, Bandinelli S, Dayhoff-Brannigan M, Giacomini V, Corsi AM, Guralnik JM, Ferrucci L. Low plasma carotenoids and skeletal muscle strength decline over 6 years. J Gerontol A Biol Sci Med Sci. 2008;63:376–383. [PMC free article] [PubMed]
24. Lauretani F, Semba RD, Bandinelli S, Dayhoff-Brannigan M, Lauretani F, Corsi AM, Guralnik JM, Ferrucci L. Carotenoids as protection against disability in older persons. Rejuvenation Res. 2008;11:557–563. [PMC free article] [PubMed]
25. Lauretani F, Semba RD, Bandinelli S, Ray AL, Guralnik JM, Ferrucci L. Association of low plasma selenium concentrations with poor muscle strength in older community-dwelling adults: the InCHIANTI Study. Am J Clin Nutr. 2007;86:347–352. [PMC free article] [PubMed]
26. Beck J, Ferrucci L, Sun K, Walston J, Fried LP, Varadhan R, Guralnik JM, Semba RD. Low serum selenium concentrations are associated with poor grip strength among older women living in the community. Biofactors. 2007;29:37–44. [PMC free article] [PubMed]
27. Mecocci P, Fanó G, Fulle S, MacGarvey U, Shinobu L, Polidori MC, Cherubini A, Vecchiet J, Senin U, Beal MF. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med. 1999;26:303–308. [PubMed]
28. Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, Guralnik JM, Semba RD. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007;103:17–20. [PMC free article] [PubMed]
29. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress and severe walking disability among older women. Am J Med. 2007;120:1084–1089. [PMC free article] [PubMed]
30. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress is associated with greater mortality in older women living in the community. J Am Geriatr Soc. 2007;55:1421–1425. [PMC free article] [PubMed]
31. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr. 2003;133:933S–940S. [PubMed]
32. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–270. [PubMed]
33. Ferrucci L, Penninx BW, Volpato S, Harris TB, BandeenRoche K, Balfour J, Leveille SG, Fried LP, Md JM. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947–1954. [PubMed]
34. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, Guralnik JM, Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242–248. [PubMed]
35. Walston J, Xue Q, Semba RD, Ferrucci L, Cappola AR, Ricks M, Guralnik J, Fried LP. Antioxidants, inflammation, and mortality among women living in the community. Am J Epidemiol. 2006;163:18–26. [PubMed]
36. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S–1688S. [PubMed]
37. Bischoff Ferrari HA. Validated treatments and therapeutic perspectives regarding nutritherapy. J Nutr Health Aging. 2009;13:737–741. [PubMed] In this paper, the author extensively reviews the potential of nutritherapy for the prevention or improvement of sarcopenia.
38. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058–2065. [PubMed]
39. Shardell M, Hicks GE, Miller RR, Kritchevsky S, Andersen D, Bandinelli S, Cherubini A, Ferrucci L. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci. 2009;64:69–75. [PubMed] Using data from a population-based study of older persons, the authors found evidence of an association between serum 25(OH)D diet and the frailty syndrome.
40. Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging. 2009;13:893–898. [PubMed] This systematic review examines the most recent observational studies and clinical trials testing the relationship between Vit-D and mobility-related outcome.
41. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. [PubMed] This meta-analysis includes high-quality double-blind randomized controlled trials and examines important features such as type and dosage of vit-D supplemented.
42. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19:265–269. [PubMed]
43. Boland R. Role of vitamin D in skeletal muscle function. Endocrine Reviews. 1986;7:434–447. [PubMed]
44. Goldberg T, Cai W, Peppa M, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004;104:1287–1291. [PubMed]
45. Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation. 2006;13:343–352. [PubMed]
46. Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009;64:132–137. [PubMed] This is the first study to show an association between elevated serum AGEs and poor skeletal muscle strength in humans.
47. Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108:191–195. [PubMed] This study showed that elevated plasma carboxymethyl-lysine is independently associated with slow walking speed in older community-dwelling adults.
48. Haus JM, Carrithers JA, Trappe SW, Trappe TA. Collagen, cross-linking and advanced glycation endproducts in aging human skeletal muscle. J Appl Physiol. 2007;103:2068–2076. [PubMed]
49. Houston DK, Stevens J, Cai J, Haines PS. Dairy, fruit, and vegetable intakes and functional limitations and disability in a biracial cohort: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2005;81:515–522. [PubMed]
50. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337:a1344. [PMC free article] [PubMed]
51. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446. [PubMed]
52. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gómez-Gracia E, López-Sabater MC, Vinyoles E, Arós F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E. PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1–11. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...